|
ZNF330 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.59540191957808E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.591920E-02 |
| Normal-vs-Stage2 |
3.074200E-02 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.77435843795593E-12 |
| Stage1-vs-Stage2 |
3.290600E-01 |
| Stage1-vs-Stage3 |
2.33750019340562E-10 |
| Stage1-vs-Stage4 |
5.26429999592182E-08 |
| Stage2-vs-Stage3 |
9.475900E-03 |
| Stage2-vs-Stage4 |
1.559510E-02 |
| Stage3-vs-Stage4 |
8.913200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.16537940093076E-13 |
| Normal-vs-AfricanAmerican |
6.897600E-01 |
| Normal-vs-Asian |
3.692600E-01 |
| Caucasian-vs-AfricanAmerican |
6.693800E-02 |
| Caucasian-vs-Asian |
5.109800E-01 |
| AfricanAmerican-vs-Asian |
7.387400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.23094892454401E-12 |
| Normal-vs-Female |
4.172300E-04 |
| Male-vs-Female |
7.677900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.193400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.03069999985084E-07 |
| Normal-vs-Age(61-80Yrs) |
8.55750004191691E-09 |
| Normal-vs-Age(81-100Yrs) |
1.822200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.684000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.683800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.421200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.674800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.094640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.341450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.627000E-01 |
| Normal-vs-Grade 2 |
5.427600E-04 |
| Normal-vs-Grade 3 |
4.20560031244577E-10 |
| Normal-vs-Grade 4 |
1.626032641866E-12 |
| Grade 1-vs-Grade 2 |
1.099790E-01 |
| Grade 1-vs-Grade 3 |
1.594070E-02 |
| Grade 1-vs-Grade 4 |
7.704500E-03 |
| Grade 2-vs-Grade 3 |
3.440300E-03 |
| Grade 2-vs-Grade 4 |
1.91400000293385E-08 |
| Grade 3-vs-Grade 4 |
3.957300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.194920E-04 |
| Normal-vs-ccB subtype |
2.21789999999E-06 |
| ccA subtype-vs-ccB subtype |
7.694000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9831999997777E-07 |
| Normal-vs-N1 |
6.786600E-04 |
| N0-vs-N1 |
6.905800E-02 |
|
|
